𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comprehensive genetic analysis of relevant four genes in 49 patients with Marfan syndrome or Marfan-related phenotypes

✍ Scribed by Haruya Sakai; Remco Visser; Shiro Ikegawa; Etsuro Ito; Hironao Numabe; Yoriko Watanabe; Haruo Mikami; Tatsuro Kondoh; Hiroshi Kitoh; Ryusuke Sugiyama; Nobuhiko Okamoto; Tsutomu Ogata; Riccardo Fodde; Seiji Mizuno; Kyoko Takamura; Masayuki Egashira; Nozomu Sasaki; Sachiro Watanabe; Shigeru Nishimaki; Fumio Takada; Toshiro Nagai; Yasushi Okada; Yoshikazu Aoka; Kazushi Yasuda; Mitsuji Iwasa; Shigetoyo Kogaki; Naoki Harada; Takeshi Mizuguchi; Naomichi Matsumoto


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
170 KB
Volume
140A
Category
Article
ISSN
1552-4825

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

In order to evaluate the contribution of FBN1, FBN2, TGFBR1, and TGFBR2 mutations to the Marfan syndrome (MFS) phenotype, the four genes were analyzed by direct sequencing in 49 patients with MFS or suspected MFS as a cohort study. A total of 27 FBN1 mutations (22 novel) in 27 patients (55%, 27/49), 1 novel TGFBR1 mutation in 1 (2%, 1/49), and 2 recurrent TGFBR2 mutations in 2 (4%, 2/49) were identified. No FBN2 mutation was found. Three patients with either TGFBR1 or TGFBR2 abnormality did not fulfill the Ghent criteria, but expressed some overlapping features of MFS and Loeys–Dietz syndrome (LDS). In the remaining 19 patients, either of the genes did not show any abnormalities. This study indicated that FBN1 mutations were predominant in MFS but TGFBRs defects may account for approximately 5–10% of patients with the syndrome. © 2006 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Identification of 23 TGFBR2 and 6 TGFBR1
✍ Chantal Stheneur; Gwenaëlle Collod-Béroud; Laurence Faivre; Laurent Gouya; Gille 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB 👁 1 views

TGFBR1 and TGFBR2 gene mutations have been associated with Marfan syndrome types 1 and 2, Loeys-Dietz syndrome and isolated familial thoracic aortic aneurysms or dissection. In order to investigate the molecular and clinical spectrum of TGFBR2 mutations we screened the gene in 457 probands suspected